357 related articles for article (PubMed ID: 12627083)
21. Retrospective study of patients with pathologic N1-stage II non-small cell lung cancer.
Nakagawa T; Okumura N; Kokado Y; Miyoshi K; Matsuoka T; Kameyama K
Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):474-8. PubMed ID: 17669909
[TBL] [Abstract][Full Text] [Related]
22. Extent of lung resection in non-small lung cancer with interlobar lymph node involvement.
Gunluoglu MZ; Demir A; Turna A; Sansar D; Melek H; Dincer SI; Gurses A
Ann Thorac Cardiovasc Surg; 2011; 17(3):229-35. PubMed ID: 21697782
[TBL] [Abstract][Full Text] [Related]
23. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
[TBL] [Abstract][Full Text] [Related]
24. Does anatomical segmentectomy allow an adequate lymph node staging for cT1a non-small cell lung cancer?
Mattioli S; Ruffato A; Puma F; Daddi N; Aramini B; D'ovidio F
J Thorac Oncol; 2011 Sep; 6(9):1537-41. PubMed ID: 21642864
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
Riquet M; Manac'h D; Le Pimpec-Barthes F; Dujon A; Chehab A
Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
[TBL] [Abstract][Full Text] [Related]
26. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes of thoracoscopic lobectomy for patients with clinical N0 and pathologic N2 non-small cell lung cancer.
Zhong C; Yao F; Zhao H
Ann Thorac Surg; 2013 Mar; 95(3):987-92. PubMed ID: 23261117
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
[TBL] [Abstract][Full Text] [Related]
29. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
[TBL] [Abstract][Full Text] [Related]
30. Prognosis of unexpected and expected pathologic N1 non-small cell lung cancer.
Shin S; Kim HK; Choi YS; Kim K; Kim J; Shim YM
Ann Thorac Surg; 2013 Sep; 96(3):969-75; discussion 975-6. PubMed ID: 23916803
[TBL] [Abstract][Full Text] [Related]
31. Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy.
Okada M; Yamagishi H; Satake S; Matsuoka H; Miyamoto Y; Yoshimura M; Tsubota N
J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):814-9. PubMed ID: 10733774
[TBL] [Abstract][Full Text] [Related]
32. Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.
Kasprzyk M; Dyszkiewicz W; Piwkowski C; Brudlo M; Galecki B; Gabryel P; Gasiorowski L
Neoplasma; 2013; 60(1):62-7. PubMed ID: 23067218
[TBL] [Abstract][Full Text] [Related]
33. Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease.
Razi SS; Nguyen D; Villamizar N
J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2469-2483.e4. PubMed ID: 31928821
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
Park S; Cho S; Yum SW; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
[TBL] [Abstract][Full Text] [Related]
35. Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences.
Deslauriers J; Grégoire J; Jacques LF; Piraux M; Guojin L; Lacasse Y
Ann Thorac Surg; 2004 Apr; 77(4):1152-6; discussion 1156. PubMed ID: 15063224
[TBL] [Abstract][Full Text] [Related]
36. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases.
Yoshino I; Nakanishi R; Osaki T; Takenoyama M; Taga S; Hanagiri T; Yasumoto K
Chest; 1999 Jul; 116(1):144-9. PubMed ID: 10424518
[TBL] [Abstract][Full Text] [Related]
37. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
38. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
[TBL] [Abstract][Full Text] [Related]
39. The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system.
Shimada Y; Tsuboi M; Saji H; Miyajima K; Usuda J; Uchida O; Kajiwara N; Ohira T; Hirano T; Kato H; Ikeda N
Ann Thorac Surg; 2009 Nov; 88(5):1583-8. PubMed ID: 19853116
[TBL] [Abstract][Full Text] [Related]
40. Survival following resection of clinically occult N2 non small cell lung cancer.
Dalton R; Keller S
J Cardiovasc Surg (Torino); 1994 Dec; 35(6 Suppl 1):13-7. PubMed ID: 7775526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
